Medicare Enrolled
Dr. Samir Desai, MD
Hematology & Oncology · Utica, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Desai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Desai?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Desai
Dr. Samir Desai is a hematology & oncology specialist in Utica, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Desai performed 916 Medicare services across 510 unique beneficiaries.
Between the years covered by Open Payments, Dr. Desai received a total of $12,030 from 81 pharmaceutical and/or device companies across 588 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Desai is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 44% volume in NY
$12,030 industry payments
Medicare Practice Summary
Medicare Utilization ↗916
Medicare services
Top 44% in NY for hematology & oncology
510
Unique beneficiaries
$65
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~46 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
430 | $70 | $170 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
126 | $46 | $120 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
109 | $62 | $132 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
93 | $95 | $222 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
56 | $37 | $83 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
35 | $53 | $149 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
34 | $65 | $138 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
18 | $43 | $133 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
15 | $93 | $198 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$12,030
Total received (2018-2024)
Avg $1,719/year across 7 years
Top 23% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
81
Companies
588
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,118 (67.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,453 (12.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,389 (11.5%)
Other
Charitable contributions, space rental, and other categories
$1,071 (8.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,550
2023
$1,556
2022
$1,501
2021
$929
2020
$697
2019
$1,729
2018
$2,068
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$1,389
Novartis Pharmaceuticals Corporation
$1,071
Daiichi Sankyo Inc.
$108
Genentech USA, Inc.
$101
Amgen Inc.
$98
Incyte Corporation
$79
PFIZER INC.
$58
Acrotech Biopharma Inc.
$55
Regeneron Healthcare Solutions, Inc.
$47
PUMA BIOTECHNOLOGY, INC.
$47
Gilead Sciences, Inc.
$43
GENZYME CORPORATION
$42
Merck Sharp & Dohme LLC
$42
Ipsen Biopharmaceuticals, Inc
$39
Eisai Inc.
$38
TerSera Therapeutics LLC
$36
Exelixis Inc.
$34
Astellas Pharma US Inc
$34
ABBVIE INC.
$24
PharmaEssentia USA Corporation
$23
Stemline Therapeutics Inc.
$22
Janssen Biotech, Inc.
$21
Genmab U.S., Inc.
$21
Takeda Pharmaceuticals U.S.A., Inc.
$20
Celgene Corporation
$15
SERVIER PHARMACEUTICALS LLC
$14
Lilly USA, LLC
$14
SpringWorks Therapeutics, Inc.
$14
Top 3 companies account for 72.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$2,047
AstraZeneca Pharmaceuticals LP
$1,544
E.R. Squibb & Sons, L.L.C.
$722
Genentech USA, Inc.
$688
Amgen Inc.
$595
Merck Sharp & Dohme Corporation
$443
Pharmacyclics LLC, An AbbVie Company
$400
PFIZER INC.
$339
Incyte Corporation
$321
Daiichi Sankyo Inc.
$252
Eisai Inc.
$235
Takeda Pharmaceuticals U.S.A., Inc.
$235
Janssen Biotech, Inc.
$210
Celgene Corporation
$206
Seagen Inc.
$206
Astellas Pharma US Inc
$204
GENZYME CORPORATION
$203
Foundation Medicine, Inc.
$146
EMD Serono, Inc.
$139
Haemonetics Corporation
$138
Lilly USA, LLC
$136
Merck Sharp & Dohme LLC
$126
AVEO Pharmaceuticals, Inc.
$122
Epizyme, Inc.,
$118
Alexion Pharmaceuticals, Inc.
$117
Regeneron Healthcare Solutions, Inc.
$111
Janssen Products, LP
$100
Pharmacyclics LLC, an AbbVie Company
$94
Gilead Sciences, Inc.
$91
Myriad Genetic Laboratories, Inc.
$87
AbbVie Inc.
$86
AbbVie, Inc.
$84
Exelixis Inc.
$73
Karyopharm Therapeutics Inc.
$66
Pharmacosmos Therapeutics Inc.
$61
Acrotech Biopharma Inc.
$55
Ipsen Biopharmaceuticals, Inc
$55
TerSera Therapeutics LLC
$54
Genmab U.S., Inc.
$52
Agios Pharmaceuticals, Inc.
$50
PUMA BIOTECHNOLOGY, INC.
$47
Sirtex Medical Inc
$46
Janssen Pharmaceuticals, Inc
$46
Seattle Genetics, Inc.
$45
Puma Biotechnology, Inc.
$44
Kite Pharma, Inc.
$41
Sobi, Inc
$39
BeiGene USA, Inc.
$39
Rigel Pharmaceuticals, Inc.
$37
Helsinn Therapeutics (U.S.), Inc.
$35
SERVIER PHARMACEUTICALS LLC
$34
Clovis Oncology, Inc.
$31
Verastem, Inc.
$31
Dova Pharmaceuticals
$30
Taiho Oncology, Inc.
$28
ABBVIE INC.
$24
Teva Pharmaceuticals USA, Inc.
$24
PharmaEssentia USA Corporation
$23
Stemline Therapeutics Inc.
$22
MorphoSys, US Inc.
$22
ARRAY BIOPHARMA INC
$21
Advanced Accelerator Applications
$21
Blue Earth Diagnostics Limited
$20
TAIHO ONCOLOGY, INC.
$19
Deciphera Pharmaceuticals Inc.
$18
GlaxoSmithKline, LLC.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Mirati Therapeutics, Inc.
$17
Myovant Sciences Inc.
$16
Shire North American Group Inc
$16
Dendreon Pharmaceuticals LLC
$16
Kyowa Kirin, Inc.
$14
TESARO, Inc.
$14
Acrotech Biopharma LLC
$14
SpringWorks Therapeutics, Inc.
$14
EISAI INC.
$13
Lexicon Pharmaceuticals, Inc.
$13
Global Blood Therapeutics, Inc.
$13
Lundbeck LLC
$13
G1 Therapeutics, Inc.
$13
Fortovia Therapeutics, Inc.
$8
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · Abraxane · Alecensa · Avastin · Axumin · BAVENCIO · BELEODAQ · BENDEKA · BESPONSA · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · Creon · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Enhertu · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · Fabhalta · GAZYVA · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · Lupron Depot · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · Monoferric · NINLARO · Nerlynx · Neulasta · Nplate · OGSIVEO · ONUREG · OPDIVO · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Perjeta · Pomalyst · QINLOCK · REBLOZYL · RYDAPT · Revlimid · Rituxan · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SUTENT · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TEG6S HEMOSTASIS SYSTEM · TIBSOVO · TUKYSA · Tavalisse · Tibsovo · Tivdak · Trodelvy · VALCHLOR · VELCADE · VENCLEXTA · VERZENIO · VONVENDI · VOTRIENT · VYEPTI · Vanflyta · Venclexta · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · YERVOY · ZEJULA · ZYTIGA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (68%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
5
Per 100K population
2.2
County median income
$68,819
Nearest hospital
MOHAWK VALLEY PSYCHIATRIC CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Desai is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Desai experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Desai performed 430 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Desai receive payments from pharmaceutical companies?
Yes. Dr. Desai received a total of $12,030 from 81 companies across 588 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Desai's costs compare to other hematology & oncology specialists in Utica?
Dr. Desai's average Medicare payment per service is $65. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Desai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Utica
Browse hematology & oncology specialists in Utica ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology